Cancer Database Query Results

Scientific Papers found: Click to Expand⟱
616- VitC,    Suppression of alkaline phosphatase in prostate cancer patients by high dose intravenous Vitamin C Treatment: Three cases
- Case Report, NA, NA
PSA↓, ALP↓,
615- VitC,    High Dose IV Vitamin C and Metastatic Breast Cancer: A Case Report
- Case Report, NA, NA
OS↑, Remission↑,
607- VitC,    Intravenously administered vitamin C as cancer therapy: three cases
- Case Report, NA, NA
necrosis↑, OS↑,
620- VitC,    Case Study: High-Dose Intravenous Vitamin C in the Treatment of a Patient with Adenocarcinoma of the Kidney
- Case Report, NA, NA
OS↑,
2485- VitC,  TACE,    High-Dose Vitamin C Promotes Regression of Multiple Pulmonary Metastases Originating from Hepatocellular Carcinoma
- Case Report, HCC, NA
ROS↑, Dose↝, Dose↝, TumCG↓, Remission↑,
4617- VitD3,    Vitamin D3 and its Potential to Ameliorate Chemical and Radiation-Induced Skin Injury During Cancer Therapy
- Case Report, NA, NA
radioP↑,

Showing Research Papers: 51 to 56 of 56
Prev Page 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 56

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

mt-OXPHOS↓, 1,   ROS↑, 2,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ATP↓, 1,   ETC↓, 1,   MMP↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

CREB↓, 1,   Glycolysis↓, 2,   p‑PDKs↓, 1,   SIRT1↓, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↑, 1,   ATF2↓, 1,   necrosis↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

other↑, 2,   other↝, 5,  

Autophagy & Lysosomes(tgid=9) ⓘ

TumAuto↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

cycA1/CCNA1↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

EP2↓, 1,   HH↓, 2,   STAT3↓, 1,   TumCG↓, 3,  

Migration(tgid=13) ⓘ

i-Ca+2↓, 1,   CEA↓, 1,   TumMeta↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 5,   Hif1a↝, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   P-gp/ABCB1↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

COX2/PTGS2↓, 2,   HMGB1↓, 1,   IL1β↓, 1,   IL6↓, 3,   NF-kB↓, 3,   PSA↓, 2,   TNF-α↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

pH↝, 2,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

testos∅, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↝, 2,   ChemoSen↑, 1,   Dose↓, 2,   Dose↑, 8,   Dose↝, 25,   Dose∅, 6,   eff↓, 1,   eff↑, 11,   eff↝, 1,   selectivity↑, 3,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 3,   ALP↓, 1,   CA125↓, 2,   CEA↓, 1,   CYFRA21-1↓, 1,   IL6↓, 3,   PSA↓, 2,  

Functional Outcomes(tgid=23) ⓘ

antiNeop↑, 1,   OS↑, 23,   Pain↓, 1,   QoL↑, 5,   QoL∅, 1,   radioP↑, 1,   Remission↑, 14,   toxicity↓, 6,   toxicity↑, 3,   toxicity↝, 2,   toxicity∅, 1,   TumVol↓, 5,   Weight↑, 2,  
Total Targets: 66

Pathway results for Effect on Normal Cells:


Core Metabolism/Glycolysis(tgid=4) ⓘ

CYP3A4↓, 1,   KeyT↑, 2,  

Transcription & Epigenetics(tgid=7) ⓘ

other↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

Dose↑, 2,   Dose↝, 1,   Dose∅, 1,   eff↑, 1,  

Functional Outcomes(tgid=23) ⓘ

cognitive↑, 3,   neuroP↑, 1,   OS↑, 1,   toxicity↑, 3,   toxicity↝, 6,  

Infection & Microbiome(tgid=24) ⓘ

AntiFungal↑, 1,  
Total Targets: 14

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page